What should be monitored in an adult patient with a history of gallbladder disease after removal of a percutaneous cholecystostomy (PC) tube?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Monitoring After Percutaneous Cholecystostomy Tube Removal

After percutaneous cholecystostomy tube removal, monitor closely for bile leak and biliary peritonitis, which are the most critical complications, along with recurrent cholecystitis, bleeding from the tract site, and signs of biliary obstruction. 1, 2

Immediate Post-Removal Monitoring (First 24-72 Hours)

Signs of Bile Leak and Peritonitis

  • Watch for increasing abdominal pain, distention, fever, and peritoneal signs (guarding, rebound tenderness), as bile leak is the primary concern after premature tract disruption 1, 2
  • Monitor vital signs every 4-6 hours for hemodynamic instability, tachycardia, or fever >38.5°C 2
  • Examine the drain site for persistent bile drainage, erythema, purulence, or expanding fluid collections 2
  • Rising white blood cell count or left shift suggests developing peritonitis or infection 1, 2

Hemorrhage from Tract

  • Monitor hemoglobin levels at 24 hours post-removal, as bleeding from liver parenchyma can occur with transhepatic approach 1, 2
  • Watch for bloody drainage from the tract site, dropping hemoglobin, or signs of hemodynamic compromise 2

Early Post-Removal Period (Days 3-14)

Recurrent Biliary Disease

  • Recurrent acute cholecystitis occurs in up to 53% of patients managed with percutaneous cholecystostomy alone versus 5% with definitive cholecystectomy, making this a critical monitoring priority 2, 3
  • Monitor for return of right upper quadrant pain, fever, nausea/vomiting, and Murphy's sign 2
  • Rising inflammatory markers (CRP, WBC) or bilirubin suggest recurrent cholecystitis or cholangitis 1, 2

Biliary Obstruction

  • Check liver function tests (ALT, AST, alkaline phosphatase, bilirubin) at 1 week post-removal to detect retained common bile duct stones or cystic duct obstruction 2
  • Rising bilirubin or persistent leukocytosis indicates ongoing biliary obstruction requiring further intervention 2

Long-Term Monitoring (Weeks to Months)

External Biliary Fistula

  • Persistent bile drainage from the tract site beyond 7-10 days suggests external biliary fistula, particularly if cystic duct patency was not confirmed on pre-removal cholangiography 2, 3
  • This complication is more likely if the tube was removed without documenting free flow of contrast into the duodenum 1, 3

Recurrent Cholangitis

  • Monitor for Charcot's triad (fever, jaundice, right upper quadrant pain), especially in patients with complex bile duct anatomy or retained stones 2
  • Recurrent cholangitis is common during the waiting period before definitive treatment in patients with biliary pathology 2

Critical Pitfalls to Avoid

The most dangerous error is removing the tube before adequate tract maturation (minimum 4-6 weeks), which dramatically increases bile peritonitis risk 1, 2, 3. The guidelines emphasize that conditions like diabetes, ascites, long-term steroid therapy, and malnutrition require even longer drainage periods before removal 1, 4.

Never remove the tube without confirming biliary tree patency via cholangiography at 2-3 weeks, as cystic duct obstruction will lead to persistent external biliary fistula 1, 4, 3. The cholangiogram must demonstrate patent cystic duct, free flow into duodenum, and absence of filling defects 4, 3.

Monitoring Algorithm

  1. Day 0-3 post-removal: Daily vital signs, abdominal examination for peritoneal signs, drain site inspection, and hemoglobin check at 24 hours 2

  2. Day 3-7: Monitor for fever, abdominal pain, and obtain liver function tests if any clinical concern 2

  3. Week 1-2: Assess for recurrent right upper quadrant pain, fever, or jaundice suggesting recurrent cholecystitis 2

  4. Week 2-4: If persistent symptoms develop, obtain CT imaging to evaluate for fluid collections, abscess, or recurrent cholecystitis 2

  5. Long-term: Counsel patients that definitive cholecystectomy should be planned, as 53% will develop recurrent biliary events without definitive treatment 2, 3

When to Obtain Urgent Imaging

Obtain CT abdomen/pelvis immediately if the patient develops: peritoneal signs, hemodynamic instability, persistent fever >48 hours, or rising lactate, as these suggest bile peritonitis, abscess formation, or sepsis 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Complications to Monitor After Percutaneous Cholecystostomy Drain Placement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

T-Tube Removal Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guidelines for Percutaneous Cholecystostomy Tube Placement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.